Insights
Insights From Our Experts
Articles
Navigating the Patient Journey: Understanding, Challenges, and Solutions in Patient Journey Mapping
EVERSANA’s APAC Authors: Ankit Kulshrestha, Robin Arnold This POV explores the intricacies of Patient Journey Mapping, detailing its significance, challenges, and solutions. Patient journey mapping is a comprehensive discipline that traces a patient’s entire healthcare journey, from…
Embarking on the Care Journey: Strategies for Engaging Patients Pre- and Post-Diagnosis
Navigating the healthcare system is a complex task for any patient, but it can be particularly tricky for those who are searching for more information on their symptoms, grappling with a recent diagnosis or looking for…
Repairing the Patient Journey: How Pharma Can Fix the Obvious – and Not So Obvious – Breaking Points of Nonadherence
The challenges facing the pharmaceutical and healthcare industries to achieve and maintain proper adherence among patients are vast and wide. Alarming statistics reveal how extensive the issue truly is, impacting nearly 50% of patients with chronic…
Robotics in Healthcare: Revolutionizing Patient Care
Authors: Robin Arnold, Ankit Kulshrestha, Abheek Bose, Mayur Muley, Anant Kasodekar The launch of the PUMA 650 surgical robot in the 1980s, initially employed in brain biopsy procedures, ushered in the era of medical robots.1 From…
Incorporating Medical Science Liaisons Early and Often Amplifies Impact and Delivers Stronger Patient Outcomes
The distinctly crucial role Medical Science Liaisons (MSLs) play in the healthcare industry helps ensure success for all stakeholders involved in a patient’s treatment journey. MSLs play a significant role in bridging the gap between scientific…
Driving Patient-First Affordability in Seconds – Not Days: Accelerating Time to Therapy
Fewer than 60% of Pharmacy Benefit Manager (PBM) electronic benefit verifications (eBVs) accurately assess patients’ financial responsibilities, largely due to the industry’s reliance on AI algorithms for estimations. This leads to financial barriers for patients, hesitancy…
Adapting to Change: Examining the Implications of New EU Regulations on Commercialisation from the Perspectives of Patients, Providers, and Pharma Companies
In April, the European Federation of Pharmaceutical Industries and Associations’ (EFPIA) 2022 Patient W.A.I.T Indicator found that the average rate of availability for pharmaceuticals in Europe is 45%, down 2% on the previous year. Additionally, the…
Utilization of Indirect Treatment Comparison (ITC), External Control Arms (ECA) and Patient-Reported Outcome Measures (PROMs)
Health Technology Assessment (HTA) is crucial to assessing the effectiveness, safety and cost-effectiveness of healthcare interventions. Indirect Treatment Comparison (ITC) is one trend that has gained traction in the HTA space as a way to evaluate…
Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies Using Machine Learning and Advanced Data Analytics
Discover how EVERSANA’s cutting-edge approach is revolutionizing patient identification for cell and gene therapies. In our white paper, “Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies Using Machine Learning and Advanced…
Unlocking the Power of Data, Artificial Intelligence and Digital Innovations to Revolutionize Care for Rare Disease Patients
Posted by
Maria Kirsch , Scott Snyder , Faruk Capan , Pierantonio Russo, MD, FCPP, FAAP, STS on July 20, 20237/20/23
Rare diseases and developing and distributing the therapies that treat them create highly complex challenges for pharmaceutical manufacturers, and certainly for the patients and providers impacted by them every day. Because these diseases are often extremely…